Latest CD4 Stories
Limited success in modeling the behavior of the complex, unusual and unpredictable HIV virus has slowed efforts to develop an effective vaccine to prevent AIDS.
MELBOURNE, Australia, April 27 /PRNewswire/ -- Scientists at Australia's Burnet Institute have developed a rapid point-of-care diagnostic test for the measurement of CD4 T-cells, a marker of the immune system for people living with HIV and AIDS.
Scientists from the California Institute of Technology (Caltech) have provided the first-ever glimpse of the structure of a key proteinâ€”gp120â€”found on the surface of a specific subgroup of the human immunodeficiency virus, HIV-1.
New study from Universite de Montreal and VGTI may lead to improved defenses.
RICHMOND, Calif., Jan. 19 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
A major obstacle to HIV research is the virus's exquisite specialization for its human host â€“ meaning that scientists' traditional tools, like the humble lab mouse, can deliver only limited information.
RICHMOND, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
HAYWARD, Calif., Nov.
A new study from the Trudeau Institute in Saranac Lake, New York, demonstrates that immune system cells important for both pathogen resistance and vaccine efficacy live longer in older animals but because of this longevity acquire functional defects.
The drugs used to treat individuals infected with HIV-1 keep the virus under control and dramatically improve prognosis, but they do not eliminate the virus from the body completely, some remains hidden in immune cells known as resting CD4+ T cells.
- An imitative word; an onomatopoetic word.